These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Qualitative characteristics of iridoids of Valeriana stolonifera Czern]. Kornievs'kiĭ IuI, D'ogot' AV, Litvinenko VI. Farm Zh; 1972; 27(4):75-6. PubMed ID: 4660482 [No Abstract] [Full Text] [Related]
23. [Electrophysiological studies on the antiarrhythmic effect of the water extract of valerian (author's transl)]. Wang YL, Hsu SG, Fan SF. Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(4):275-82. PubMed ID: 553026 [No Abstract] [Full Text] [Related]
24. [Valepotriates in the leaves of Valeriana jatamansii (author's transl)]. Hölzl J, Jurcic K. Planta Med; 1975 Mar; 27(2):133-9. PubMed ID: 1121526 [No Abstract] [Full Text] [Related]
26. [Medicinal plants as objects of hygienic monitoring]. Listov SA. Gig Sanit; 1989 Dec; (12):89-90. PubMed ID: 2628211 [No Abstract] [Full Text] [Related]
27. [The problem of pesticide and heavy metal residues in plant-derived drugs used in the pharmaceutical industry]. Lorusso S, Camoni I, Chiacchierini E. Nuovi Ann Ig Microbiol; 1985 Dec; 36(3):169-80. PubMed ID: 3842759 [No Abstract] [Full Text] [Related]
28. [Evolution of the concentration of valtrates in Valeriana procurrens Wallr. cultivated in conditioned media]. Mélotte R. J Pharm Belg; 1973 Dec; 28(3):373-83. PubMed ID: 4733874 [No Abstract] [Full Text] [Related]
29. [Valeriana officinalis and Crataegus oxyacantha: toxicity from repeated administration and pharmacologic investigations]. Fehri B, Aiache JM, Boukef K, Memmi A, Hizaoui B. J Pharm Belg; 1991 Dec; 46(3):165-76. PubMed ID: 1757878 [Abstract] [Full Text] [Related]
30. [Dynamics of the seasonal accumulation of the main groups of chemical compounds of Valeriana stolonifera czern]. Kornievsk'iĭ IuI, Koreshchuk KE. Farm Zh; 1971 Dec; 26(2):67-70. PubMed ID: 5152491 [No Abstract] [Full Text] [Related]
31. HPLC analysis of valepotriates in the North American genera Plectritis and Valeriana. Foerster W, Becker H, Rodriguez E. Planta Med; 1984 Feb; 50(1):7-9. PubMed ID: 6739575 [No Abstract] [Full Text] [Related]
32. [Tests of "industrial lyophilization" of medicinal plants. 3. Valeriana officinalis L. Influence of lyophilization on the quality of the drug]. Paris R, Besson P, Hérisset A. Ann Pharm Fr; 1966 Nov; 24(11):669-74. PubMed ID: 5987652 [No Abstract] [Full Text] [Related]
33. The Toxicological Risk Assessment of Lead and Cadmium in Valeriana officinalis L., radix (Valerian root) as Herbal Medicinal Product for the Relief of Mild Nervous Tension and Sleep Disorders Available in Polish Pharmacies. Jurowski K, Fołta M, Tatar B, Berkoz M, Krośniak M. Biol Trace Elem Res; 2022 Feb; 200(2):904-909. PubMed ID: 33792859 [Abstract] [Full Text] [Related]
36. [Procedure for measuring the value of valproates in pharmacopoeia-prescribed valeriana tinctures]. Liptákné CE, Pethes E. Acta Pharm Hung; 1978 Jul; 48(4):161-7. PubMed ID: 707108 [No Abstract] [Full Text] [Related]
38. To the pharmacology of iridoids. Petkov V, Manolov P. Agressologie; 1975 Jul; 16 Spec No B():25-30. PubMed ID: 1232824 [No Abstract] [Full Text] [Related]
39. [Callus cultures of a Valerian species. 1. Installation of a callus culture of Valeriana Wallichii DC and 1st analytical studies]. Becker H, Schrall R, Hartmann W. Arch Pharm (Weinheim); 1977 Jun; 310(6):481-4. PubMed ID: 883877 [No Abstract] [Full Text] [Related]
40. [Estimation of current maximum permissible levels of total specific activity of radionuclide mixture in the liquid forms of drugs and medicinal raw materials]. Prokof'ev ON, Antonova VA, Seditskaia ZL. Gig Sanit; 1992 Jun; (5-6):31-4. PubMed ID: 1398171 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]